However, GLP-1 medications remained relatively niche until Wegovy's approval in June 2021, which sparked the explosive popularity surge in weight loss applications
2023, If you want to explore this further: If you want to explore this further: If you want to explore this further: 8, 14 Mongioi, L., et al
The scope and modality of imaging should be individualized, guided by clinical judgment and risk stratification
Two paths
Regular monitoring and multidisciplinary input, including dietetic support, are essential to ensure safe and effective use of Wegovy in this population
Kumar notes that GLP-1 drugs that are available in vials (such as the single-dose 2.5 mg and 5 mg vials of Zepbound) or dial-a-dose pens (like Ozempic) are better suited for microdosing